Anteris Technologies Global/$AVR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Anteris Technologies Global

Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.

Ticker

$AVR
Sector
Primary listing

Employees

174

Headquarters

Toowong, Australia

AVR Metrics

BasicAdvanced
$625M
-
-$2.55
0.42
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $AVR

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs